Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow EW
Edwards Lifesciences Corporation (EW) Return on equity
Edwards Lifesciences Corporation's return on equity over the twelve months to 30 June 2026 was 9.42%, down 1.1 percentage points from fiscal 2025 (10.5%). Over the past ten years it has ranged from 10.5% (fiscal 2025) to 49.8% (fiscal 2024) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 10.5% | (39.23) |
| FY2024 | 49.8% | 27.36 |
| FY2023 | 22.4% | (3.75) |
| FY2022 | 26.1% | (2.74) |
| FY2021 | 28.9% | 10.00 |
| FY2020 | 18.9% | (9.85) |
| FY2019 | 28.7% | 5.04 |
| FY2018 | 23.7% | 2.75 |
| FY2017 | 20.9% | (1.30) |
| FY2016 | 22.2% | 1.16 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| SYK Stryker Corporation compare | 16.5% |
| BSX Boston Scientific Corporation compare | 15.4% |
| STE STERIS plc compare | 11.4% |
| MDT Medtronic PLC compare | 10.6% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| EW Edwards Lifesciences Corporation | 9.42% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.41% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement